Why I’m Buying ICON PLC at 52-Week Lows 📉

ICON PLC is vital to the pharmaceutical industry, and their stock is at 52-week lows. I believe ICON is a wonderful company, and I think ICLR stock is undervalued today based on their low valuation on a price to sales, PE, and price to free cash flow basis. Their business is experiencing some hiccups, with elevated levels of cancellations lately from their pharma partners. However, their backlog remains strong, their balance sheet is stable, and they recently approved a stock repurchase plan. As always, this is not financial advice. :)

00:00 ICON Stock Hitting 52-Week Lows
00:27 What Does ICON PLC Do?
02:00 Why is ICLR Stock Down?
04:45 ICLR Stock Analysis
09:28 My Thoughts on ICLR Stock

$ICLR